Colonic mucosal -synuclein lacks specificity as a biomarker for Parkinson disease
Editors' Note: Commenting on the lack of specificity of colonic mucosal α-synuclein as a potential biomarker in Parkinson disease, Ruffmann and Parkkinen share their “Discovery study” findings, which in part agree with the work of Visanji et al. and in part raise additional questions. Furthermo...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
American Academy of Neurology
2015
|